Trial Spotlight

FORAGER-1; NCT05614739

A Phase 1, Open-label, Multicenter Study of LY3866288 (LOXO-435) in Locally Advanced or Metastatic Solid Tumors Including Urothelial Cancer with FGFR3 Alterationsa

Filter our pipeline to find information relevant to you. Search results will appear below.
Recruiting

Breast

Mechanism of Action
Molecule
Trial Identifier
Phase
Status
CDK4/6 Inhibitor
3
Active, not recruiting
CDK4/6 Inhibitor
3
Active, not recruiting
CDK4/6 Inhibitor
3
Active, not recruiting
CDK4/6 Inhibitor
3
Active, not recruiting
FRα Antibody-Drug Conjugate
1
Recruiting
Nectin-4 Antibody-Drug Conjugate 1
1
Recruiting
Nectin-4 Antibody-Drug Conjugate 2
1
Active, not recruiting
Pan-Mutant Selective PI3Kα Inhibitor
1
Recruiting
Selective Estrogen Receptor Degrader
1
Active, not recruiting
Selective Estrogen Receptor Degrader
3
Active, not recruiting
Selective Estrogen Receptor Degrader
3
Recruiting